340,000 Token Launches Push Uniswap Into Discovery

There’s a number doing the rounds: 340,000. That’s the ballpark count people cite for how many tokens have been fired into EVM land over a recent stretch. However you slice it, the launch machine is redlining. And Uniswap is getting pulled straight into price discovery.

Not just as a place where things trade after the fact. Uniswap’s own tooling now runs auctions that set the opening price and seed the pool at that level. That’s a real shift in the exchange’s role.

Below, I’ll unpack why this is happening, how Uniswap’s Continuous Clearing Auctions actually work, and what you need to watch if you’re bidding on day one or listing a token yourself.

Point Details Launch surge Hundreds of thousands of token contracts deployed across EVM chains; the “340,000” figure captures the sheer scale and churn of recent launches. Uniswap as discovery Uniswap’s Continuous Clearing Auctions (CCA) set on-chain clearing prices and seed Uniswap v4 pools at that price, pushing Uniswap into primary price discovery. Pons data point Dune-tracked Pons completed 66,000+ launches with about $380M cumulative volume as of July 20, 2026, showing the size and speed of this launch wave (KuCoin (reporting Dune)). Mechanics matter CCAs batch orders, find a clearing price, then seed the v4 pair so trading starts where the auction settled (DefiLlama Research; Uniswap). New venues Uniswap deployed v2/v3/v4 and UniswapX on Robinhood Chain at launch, adding a fresh flow of retail-adjacent order flow to its discovery stack (Uniswap Labs blog). Risk profile High failure rate among new tokens, smart contract risk, MEV, thin liquidity, and regulatory uncertainty. Treat early participation as speculative.

What 340k launches actually means

The 340,000 headline is less a precise census and more a sign of the times. Token creation has become cheap, fast, and automated. A single deployer can spray dozens of contracts a day. Meme seasons pull in bots that fork, tweak, and relist with microscopic changes. Some of those contracts never trade. Others see a blip of activity and die. A handful stick.

So when you hear 340k, think order of magnitude. It tells you the funnel is huge and noisy. It also tells you the old model — list on a CEX after months of courting market makers — just doesn’t cover this firehose. Most of these tokens will live and die on-chain, and a lot of them will clear price for the first time on Uniswap.

That’s why Uniswap building native discovery tools isn’t a side quest. It’s a necessary adaptation to where issuance now happens.

Uniswap turns liquidity into discovery

The pivot is straightforward: instead of passively waiting for someone to create a pool and let price wobble into place, Uniswap’s Liquidity Launchpad runs a Continuous Clearing Auction (CCA), finds a clearing price, and then seeds a v4 pool at that level.

DefiLlama’s Boardwalk report documents this design clearly: CCAs do on-chain price discovery and seed Uniswap v4 pools, acting as a bridge between a launch event and a tradable market (DefiLlama Research).

Uniswap’s own product page says the same thing, spelling out that auctions are built to discover price on-chain and initialize v4 liquidity at the discovered price (Uniswap).

How a CCA flows, in plain English

• Orders are collected over a window. You’re not fighting tick-by-tick; you’re lining up into a batch.
• The system finds the price where the most volume can clear. That’s the clearing price.
• Allocations are filled at that single price, not a sliding ladder.
• Right after that, a v4 pool is seeded at the auction price so secondary trading starts where the auction left off.

This helps cut the chaos you get when someone YOLOs a tiny pool and bots slam it around for 30 minutes. It’s not magic. But for legitimate launches, it’s cleaner.

CCA vs throwing a pool live

Approach What you get Trade-offs CCA + v4 seeding Single clearing price, batch fairness, immediate pool at that price More prep, rules to follow, auction window risk if sentiment flips Direct pool bootstrap Instant trading, minimal coordination Wild slippage, easy MEV targets, manipulative anchors OTC/fair drop then pool Some price signal from OTC, curated distribution Opaque fills, secondary market shock when pool opens

Early auctions can still be gamed. They just raise the cost of obvious manipulation and make the “first print” less of a dart throw.

Pons shows the scale — and the noise

If you want a feel for the pipeline, look at Pons. On-chain dashboards tracking Pons show over 66,000 token launches completed with roughly $380 million in cumulative trading volume as of 4:00 PM UTC on July 20, 2026 (KuCoin (reporting Dune)).

That’s a staggering count. But it also hints at the hit rate problem. If nearly all of those tokens exist, only a fraction pulled meaningful liquidity. A smaller fraction sustained it. And yet, these launches still drive a ton of first-touch demand, which bleeds directly into the pools that pick them up — often on Uniswap.

The practical takeaway: the faucet isn’t slowing down. So discovery tooling has to scale. Auctions, pooled liquidity templates, rollout rails — that’s the stack Uniswap is building toward.

Robinhood Chain gave Uniswap a new runway

Another piece of the puzzle is venue. When Robinhood Chain went live on July 1, 2026, Uniswap deployed v2, v3, v4, and UniswapX out of the gate, becoming the primary public AMM at launch (Uniswap Labs blog).

That matters because a lot of fresh retail-adjacent flow will try things there first. If Uniswap is the default lane on that chain, discovery doesn’t detour elsewhere. It lands in Uniswap’s liquidity. From there, activity can spider out to other EVMs via bridges, but the price imprint often starts where the first legit pool sits.

Layer those deployments with CCAs and you’ve got a full pipeline: launch page, auction, seed pool, secondary trading. It’s not a guarantee of quality — it’s a process that can scale without imploding at the first trade.

How to approach a CCA if you’re tempted to bid

Quick reality check: most new tokens go to zero or near it. This is not advice. It’s a simple flow to keep you from tripping over obvious stuff.

Step-by-step

1. Find the official auction link. Spoofs are everywhere. Cross-check the project’s site and socials. If it’s Uniswap’s CCA, the docs and URLs should align with Uniswap’s product page.
2. Read the auction parameters. Supply on offer, reserve price (if any), accepted assets, start/end times, allocation rules, refund logic.
3. Decide your max willingness to pay. Not the hype price — the price you’re fine holding through a 50% drawdown.
4. Place the order and walk away. CCAs aren’t a race. Over-tinkering just invites mistakes and extra gas.
5. After settlement, check the seeded v4 pool. Confirm the token address, fee tier, and that the initial price matches the clearing price.
6. Set alerts, not 24/7 screens. Day-one swings can be brutal as price meets real liquidity.

Pro tip: If there’s a reserve price way above comps, treat it as marketing, not a floor. A no-fill outcome can actually be the best protection from overpaying.

Red flags to pause on

• Tokenomics that hand a majority to insiders or unlock a giant chunk in the first week.
• Opaque treasury wallets or “multi-sig” that resolves to one hot address.
• Audits that aren’t audits. PDFs without a firm name or commit hash are noise.
• Over-optimized Twitter hype, under-optimized code repos.

Signals a new token might actually survive the week

None of this guarantees anything. But these are the tells I check before touching a launch:

• Distribution that isn’t a joke. Reasonable float at launch, vesting that doesn’t cliff into oblivion.
• A clear buyer cohort. Not just “the community.” A known group that benefits if the token exists and trades.
• Some builder receipts. Live code or an existing product. A roadmap isn’t a product.
• Liquidity commitments. Named market makers or on-chain incentives that last longer than a weekend.
• Credible venue choices. If they’re using Uniswap’s CCA and seeding a v4 pool, show me the parameters. If not, explain the plan.

Liquidity games and risks to watch

Price discovery is messy. CCAs tidy up one part of the mess. The rest is still there:

• Smart contract risk. Auctions and tokens run on code. If the contract has a bug or a malicious function, all bets are off.
• MEV and sandwiching. Auctions reduce sniping, but once the pool is live, toxic order flow comes back. Use limit-like flows or RFQ routes where possible.
• Custody and wallets. If you’re switching chains (say, bridging into Robinhood Chain or elsewhere), triple check addresses and approvals. Revoke spend permissions you don’t need.
• Regulatory friction. Depending on jurisdiction, participating in token sales may have constraints. Projects can change terms pre-settlement to stay compliant. Read the fine print.
• Liquidity mirages. TVL screenshots can hide concentrated LP positions. If one LP yanks, slippage explodes.

Guardrails you can actually use

• Cap your exposure per launch. The hit rate doesn’t justify going heavy.
• Prefer auctions or listings with transparent parameters over stealth pool drops.
• Set post-settlement alerts at 10–15% bands. If momentum dies, don’t become exit liquidity.
• Track whale wallets that got big fills. If they dump immediately, that’s your signal.

For teams: designing a launch that doesn’t backfire

If you’re on the other side of the book, CCAs give you structure, but you still have choices to make.

Checklist before you hit “create auction”

• Reserve price logic. Set it based on comps and runway, not vanity. If it’s too high, you get a failed auction and a credibility dent.
• Float and vesting. Put enough in circulation to enable real markets, but don’t set up a week-one unlock cliff.
• Post-auction liquidity. Who’s LPing the v4 pool beyond the initial seed? Outline incentives and duration.
• Market structure. If you plan a Robinhood Chain pool plus a mainnet pool, explain routing and bridges. Fragmented liquidity confuses users.
• Docs and comms. Publish the token address early, pin the auction link, and keep everything in one place to reduce spoof risk.

Handled well, CCAs can save you from the worst parts of day-one chaos. Handled badly, they just move the chaos into a nicer wrapper.

Why Uniswap is the center of gravity right now

Three forces line up here:

• Launch velocity. With Pons-scale pipelines pushing tens of thousands of creations into the wild, there’s constant demand for first pricing (KuCoin (reporting Dune)).
• Native discovery tools. Uniswap’s CCAs explicitly target on-chain price discovery and seed v4 pools at the discovered price (DefiLlama Research; Uniswap).
• New distribution lanes. Uniswap’s presence on Robinhood Chain as the go-to AMM at launch funnels fresh users and assets into its pools (Uniswap Labs blog).

Put together, Uniswap isn’t just where price happens to be shown. It’s where price is increasingly made, at least for the long tail. That carries responsibility — and a lot of temptation for speculators.

Stay ahead without the noise

If you want more straight-shot explainers like this, Crypto Daily tracks launch mechanics, on-chain flows, and the stuff that actually changes outcomes. You can find our latest coverage at cryptodaily.co.uk.

Frequently Asked Questions

Is the “340,000 launches” number verified?

It captures scale more than a single authoritative count. Token creation is fragmented across chains and dashboards. Treat it as directional, not a certified tally.

What exactly is a Continuous Clearing Auction on Uniswap?

It’s a batch auction that collects orders, finds a single clearing price, fills allocations at that price, and then seeds a Uniswap v4 pool at that level. Uniswap’s product page spells this out, framing CCAs as on-chain price discovery and liquidity seeding.

Why would a team choose a CCA over just launching a pool?

To avoid chaotic first prints and extreme slippage. A CCA can improve fairness and give a cleaner opening price. The trade-off is more prep and the risk that sentiment changes during the auction window.

Where does Robinhood Chain fit into Uniswap’s role in discovery?

Uniswap deployed v2/v3/v4 and UniswapX on Robinhood Chain at mainnet, positioning it as the default AMM there. That setup routes early trading in new assets into Uniswap’s pools and tooling on that chain.

Are most of these new launches worth trading?

Most won’t hold value. The hit rate is low, and the risks — contract bugs, thin liquidity, manipulation — are high. If you participate, cap exposure and assume high volatility.

How do I check if an auction link is real?

Cross-check the project’s website and socials, verify the token address, and confirm the interface matches Uniswap’s official CCA domain if applicable. Be wary of lookalike URLs and fake X accounts.

What changes after the auction ends?

The v4 pool seeded at the clearing price becomes the main venue. That’s where MEV, liquidity shifts, and real price discovery continue. Set alerts and expect big swings in the first sessions.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

* This article was originally published here

After Zapper: Where DeFi Users Can Track Their Positions

If you used Zapper to make sense of your wallets, LPs, and random farm experiments, the lights are going off. The team announced it’s winding down, and the site, mobile apps, and API are scheduled to shut on August 3, 2026. That’s a big gap to fill if you checked it daily.

This guide walks through practical replacements, the trade-offs on privacy and features, and a simple migration checklist you can do in a weekend. It matters right now because the cutoff date is set and your labels, watchlists, and API calls won’t be there the next morning.

Zapper scaled to millions of monthly users and processed billions in volume, so a lot of people are moving at once. Expect some crowding on alternatives and plan ahead. The facts on timing and history are here: the July 8 wind-down announcement and August 3 shutdown window, plus Zapper’s reach at peak and funding background The Block. Reporting also flags what stops working exactly and that API customers are being emailed migration steps Cryptool (blog).

The fastest like-for-like replacements are DeBank, Zerion, DeFiLlama’s Portfolio, Rotki, and CoinStats. DeBank and Zerion feel closest to a Zapper-style all-in-one view, DeFiLlama is lean and clean for on-chain reads, Rotki is for privacy-first locals, and CoinStats covers a lot of CEX plus DeFi. If you need an API, shortlist DeFiLlama’s public endpoints and commercial indexers while you rebuild anything that pointed at Zapper’s API.

• DeBank and Zerion for quick, familiar dashboards and mobile.
• DeFiLlama Portfolio for broad chain coverage and a lightweight feel.
• Rotki if you want local data with no cloud dependencies.
• CoinStats for mixed CEX plus DeFi portfolios.
• For APIs, pivot to DeFiLlama endpoints or major indexers while you refactor.

Which dashboards replace Zapper’s all-in-one view best?

If you liked Zapper’s wallet connect and instant position breakdowns, start with DeBank and Zerion. Both pull balances, DeFi positions, and NFTs across popular chains with a clean, familiar layout. You paste or connect a wallet and it just appears. Mobile apps exist, so you’re not stuck at a desk.

DeFiLlama’s Portfolio is simpler, which is part of the charm. It reads wallets across many chains and gets you to the core question fast: what do I hold and where? It isn’t trying to be a wallet or ad platform. It’s a practical read-only pane for most of what you need, including basic LP and staking detections.

Rotki is where you go if you want everything to live locally on your machine. It’s open source, more technical to set up, and great if privacy is your top priority. CoinStats can work if your portfolio includes CEX accounts, banked stablecoin rails, and on-chain wallets that you want under one roof.

How do the top options compare side by side?

Here’s a quick feature snapshot. It’s intentionally high level since chains and features change often. Always verify current coverage on the project site before moving over.

Tool Best for Data model Mobile NFT view Notes DeBank Fast all-in-one DeFi reads Hosted, read-only wallet connect Yes Yes Strong DeFi position parsing across major chains Zerion Portfolio + wallet experience Hosted, optional in-app wallet Yes Yes Good UX if you want tracking and transacting together DeFiLlama Portfolio Lightweight on-chain dashboard Hosted, read-only Web-first Basic Broad chain coverage and transparent methodology Rotki Privacy, local custody of data Local desktop app No Limited Open source, more setup, strong for power users CoinStats Mixed CEX + DeFi tracking Hosted with exchange connections Yes Yes Convenient if you bridge on and off exchanges often

These five cover the bulk of use cases. If you only need wallet balances and simple LP exposure, DeFiLlama may be enough. If you want to track and occasionally trade in one place, Zerion’s built-in wallet is handy. If you care about not leaking portfolio data to a third party, Rotki stands out.

What changed with Zapper and why does it matter?

The short version is finality. Zapper said on July 8, 2026 that it would wind down and set August 3, 2026 as the shutdown date for the website, mobile apps, and API. Coverage also recapped that the project reached roughly 2 million monthly active users and processed over $13 billion of transaction volume at its peak The Block. That scale tells you how many wallets are moving elsewhere at once.

It also matters because more than the UI is going away. Articles and vendor posts are explicit that the zapper.xyz dashboard, mobile apps, and API all stop on that date and that existing API customers are getting migration emails Cryptool (blog). So if you automated reports or had internal tools pinging Zapper endpoints, this is not just a bookmark change.

For context, Zapper’s wind-down stories also reference its funding journey, including a $15 million Series A led by Framework Ventures back in May 2021, plus an earlier seed round The Block. It reminds us that even well-backed tools in crypto can sunset. Plan for portability.

How should I think about privacy and custody with trackers?

Portfolio trackers see what you hold. That alone is sensitive. The first split is hosted dashboards that load your wallet data on their servers versus local tools that keep it on your machine. Hosted tools are faster to start, but you trade some privacy and depend on their uptime and policies.

Local-first apps like Rotki store data on your device. No cloud, no centralized account by default. The tradeoff is convenience. You’ll maintain the app and, sometimes, your own indexing sources. If you’re a desk or a high-profile wallet, the privacy win can be worth the extra work.

Either way, connect wallets in watch-only mode unless you’re explicitly signing a transaction. Check settings for data sharing, analytics toggles, and whether your addresses are linked to an account email. If you want to be extra careful, create fresh watch-only addresses that you label internally and don’t attach to your name anywhere.

Pro tip: label every address as you add it. Even a short note like “main hot,” “vault,” or “old LP farm” will save you hours when you’re reconciling positions or pulling tax exports later.

Which tool actually fits my setup?

Different stacks, different answers. If you’re mostly DeFi-native across a few EVM chains with some NFTs, DeBank or Zerion will feel right away comfortable. They’re quick, have decent position parsing, and let you peek at friends’ or treasury wallets to benchmark exposure.

If you operate many addresses across many chains and just want a dependable read-only pane that loads fast, DeFiLlama’s Portfolio keeps it simple. It won’t try to sell you anything or steer you into swaps. It focuses on showing balances and common DeFi positions cleanly.

If you’re compliance heavy or privacy obsessed, Rotki is the path. It can pair with tax workflows and lets you keep sensitive data off third-party servers. If you have a lot of centralized exchange balances in the mix, CoinStats can centralize those with your on-chain wallets so you don’t juggle tabs.

What about APIs and reports after Zapper’s shutdown?

Since Zapper’s API is going away on August 3 and customers are being contacted about migrations Cryptool (blog), treat this like a small refactor. First, list every script, sheet, or dashboard that hits Zapper endpoints. Then map each call to a replacement. Public endpoints from data aggregators can fill gaps for basic token balances and prices, while commercial indexers cover deeper position data.

If you need institutional-grade feeds, consider splitting your stack: one source for prices, one for balances, one for position decoding. Redundancy helps. Document rate limits and authentication in one place so the next rotation on your team can keep the lights on.

For compliance exports, test CSVs from your new tracker against last month’s numbers. Don’t wait until month-end. Reconcile a single wallet deeply to make sure fees, LP tokens, and staked positions land in the right buckets before you switch everything over.

Can I do this in a weekend? A simple migration checklist

Yes, if you scope it. Here’s a tight checklist that covers most setups:

• Inventory: list all addresses, ENS names, and any watchlists you used in Zapper.
• Export: download or screenshot Zapper views you rely on before the cutoff for reference.
• Select: choose a primary tracker and a backup. Add 3 to 5 core wallets first.
• Label: recreate key labels while they’re fresh in your head.
• Reconcile: compare totals and a few positions wallet by wallet.
• Automate: rebuild any scripts using new APIs and note rate limits.
• Review: check privacy settings, disable analytics if offered, and keep sign-only to transactions.

If you run a team wallet, agree on which app is the source of truth. Write it down. Nothing’s worse than two dashboards showing different numbers and everyone arguing about which is “real.”

Common Mistakes

1. Waiting until after the shutdown. Avoid scrambling by setting up a replacement and taking screenshots or exports now. You’ll want a reference point.
2. Forgetting labels and notes. Your memory fades. Recreate labels as you add wallets to the new tool, not a week later.
3. Assuming all chains and vaults are supported. Test one complex position early. If it doesn’t parse, decide if you’ll track it manually or pick another tool.
4. Connecting wallets and signing blindly. Use watch-only wherever possible. Only sign when you intend to transact.
5. Ignoring API differences. Rate limits, pagination, and schemas vary. Update scripts and add retries rather than copy-pasting old code.
6. Mixing work and personal wallets in one account. Separate them to reduce leaks and simplify reporting.

If you want more practical explainers like this, Crypto Daily tracks the moving pieces so you don’t have to. Check the latest breakdowns and features at Crypto Daily.

Frequently Asked Questions

Will my Zapper data vanish on August 3, 2026?

Yes, the public site, apps, and API are scheduled to shut then, so plan as if you’ll lose access. The shutdown timing and scope have been reported and reiterated in July coverage The Block and vendor guidance Cryptool (blog).

How do I track positions that my new dashboard doesn’t recognize?

Use a second tracker as a backup and keep a small manual sheet for edge cases. Most tools will display the tokens, but some complex vaults or vested positions may require manual tagging until support improves.

What if my portfolio includes centralized exchanges?

Pick a tracker that supports exchange connections and treat API keys with care. Rotate keys regularly, restrict permissions to read-only, and consider keeping sensitive balances out of any third-party account if privacy is a concern.

Do I need to pay for a premium plan?

Not always. Many dashboards cover basics for free. You might pay if you need more wallets, deeper history, tax exports, or team features. Start free, see what’s missing, then upgrade only if it saves time.

Can I import my Zapper labels into another app?

There isn’t a universal importer. If you can export anything from Zapper before the cutoff, do it. Otherwise, rebuild labels as you go and keep a simple mapping doc so you don’t lose context.

Is it safe to connect my wallet to these tools?

Viewing is generally safe because it’s read-only. That said, only sign transactions you initiate, verify URLs, and avoid extensions or pop-ups that ask for broad approvals. If unsure, use a fresh watch-only address for tracking.

How do teams manage multi-sig and treasury tracking?

Create a dedicated account in your chosen dashboard for the treasury, add the multi-sig and related wallets, and lock down who can edit labels. Keep routine exports in a shared drive so finance and ops have the same numbers.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

* This article was originally published here

Base B20 Token Standard: How Native Tokens Differ From ERC-20

Base just switched on something big for token builders: a native token standard called B20. If you’ve been minting ERC-20s for years, B20 looks familiar on the surface — but the guts are different. This piece breaks down what changed, why it matters for issuers and traders, and what to watch next.

We’ll compare B20 to ERC-20 in plain English, walk through how the factory actually works, and flag early on-chain patterns from launch week. There’s a checklist for safe deployment and a few traps to avoid if you’re buying into new B20 tickers.

Editor's note: I watched Base’s B20 go live in early July and the first hours were exactly what you’d expect: a torrent of meme mints, identical supplies, and thin pools that moved on whispers. Our desk tested provenance checks against the 0xB20f factory and the 0xB200 token prefix, which saved time we usually waste on contract spelunking. Conversations with infra teams in July pointed to quick wallet parity but slower explorer upgrades for showing policy states. I’m keeping an eye on the fee-in-B20 plan from Base’s Cobalt notes; if that ships, user onboarding for new tokens could get a lot smoother. — Elliot Veynor

B20 is Base’s native token standard that runs as a precompile inside the node, not as a user-deployed Solidity contract. It mirrors ERC-20 function selectors so wallets and indexers treat B20 like a normal fungible token, but it adds issuer-level controls like transfer policies, role-based permissions, supply caps, freeze-and-seize, memos, and built-in permit. Base activated B20 on July 8, 2026, and has more features queued on the roadmap.

• Native precompile with ERC-20 parity for UX compatibility
• Issuer Toolkit: allowlists/blocklists, roles, caps, freeze-and-seize, memos, ERC-2612 permit
• Deterministic addresses via a factory at 0xB20f…; B20 tokens start 0xB200…
• Early activity skewed to memecoins; no real RWAs or stablecoins in first sample
• Planned ability to pay fees in B20 tokens is on Base’s roadmap

How does B20 actually work under the hood?

B20 lives inside Base’s node as a native precompile. Instead of deploying a Solidity ERC-20 contract, issuers call the B20 factory, which mints a token implementation backed by the node’s Rust code. Because the interface mirrors standard ERC-20 selectors, most wallets, indexers, and tools see a B20 token and interact with it like any fungible asset.

The factory sits at a fixed address — 0xB20f000000000000000000000000000000000000 — and tokens created by it have deterministic addresses with a distinctive 0xB200… prefix. That makes basic provenance checks faster and reduces the chance of collisions or weird proxy patterns you sometimes see with contract-based mints. These deployment details, including the selector parity and Issuer Toolkit, are documented in developer explainers and Base references (Chainstack).

Base officially activated B20 on July 8, 2026 as part of its Beryl upgrade cycle, and the upgrade changelog flags it as live on mainnet (Base — Upgrades changelog). The same roadmap notes future improvements tied to Cobalt planning entries, including a path to pay fees in B20 (more on that later).

What separates B20 from ERC-20 in practice?

Function names look the same. Everything else — the execution model, deployment flow, and built-in controls — is different. Think of ERC-20 as “you ship a contract with whatever features you add,” while B20 is “the chain ships the core logic and you flip switches from an issuer console.”

The biggest upgrade is the Issuer Toolkit. Out of the box, B20 supports role-based access, transfer policy rules (allowlists or blocklists), supply caps, freeze-and-seize via burnBlocked, optional on-chain memos, and ERC‑2612 permit for gasless approvals (Chainstack). All of that is native, so issuers don’t need to stitch together third-party libraries and hope audits catch edge cases.

Aspect B20 (Base) ERC-20 (typical) Implementation Native precompile in node (Rust) Solidity/Vyper smart contract deployed by user Selector compatibility Matches ERC-20 function selectors Standard ERC-20 Issuer controls Built-in roles, policies, caps, freeze-and-seize, memos, permit Only if coded in; varies across tokens Addressing Factory: 0xB20f…; tokens deterministic, start 0xB200… Arbitrary contract addresses per deployer Audit surface Shared native logic maintained by the chain Each contract is custom and needs its own audit Gas/efficiency Potentially leaner execution via precompile Depends on contract code; often heavier Fees in token Planned on Base roadmap (EIP‑8130 path) Chain-dependent; not standard

For end users, near-term UX should feel familiar: balances, transfers, approvals, spending via permit. The difference is what issuers can do behind the scenes — from predefining allowed counterparties to freezing assets in compliance events. Whether that’s a feature or a red flag depends on your use case.

What did launch week show on-chain?

On day one, B20 mostly turned into a mint cannon for memecoins. DEXTools pulled registry logs from the first ~7 hours after activation and counted roughly 2,000 B20 tokens created. In a 250-token sample, 98.4% used 18 decimals, 64% set total supply to exactly 1,000,000,000, and there were zero genuine stablecoins or RWAs in the set (DEXTools News).

None of that means B20 can’t host serious assets. It just shows what happens when you lower mint friction on a chain that already loves retail flow. Expect noise before signal. Standards tend to get stress-tested by meme traders first, then picked up by more structured projects once the edges are known.

For now, assume most fresh B20 tickers are experiments or outright punts. If you’re allocating, use small sizes, confirm transfer policies aren’t trapping you, and check who holds the issuer roles before you touch a pool.

How should issuers use the B20 toolkit without painting themselves into a corner?

Issuer power cuts both ways. B20 makes it easy to ship guardrails, but misconfigured policies can wreck UX or liquidity. Start with the minimum viable controls and ramp up only when there’s a clear requirement.

• Decide roles early. Map who can mint, pause, set policies, and rotate keys. Document recovery paths.
• Prefer allowlists for pilots, then loosen to blocklists once you’re comfortable with circulation risks.
• Set a supply cap and stick to it. If you’ll raise it later, pre-announce conditions and timelines.
• Use memos sparingly. They’re useful for provenance, but keep private data off-chain.
• Enable permit (ERC‑2612) for smoother DEX flows and fewer failed approvals.

Pro tip: Verify provenance before integration. True B20s minted through the factory come from 0xB20f… and the token address will start 0xB200…. If those two checks fail, treat it as a regular contract token and proceed carefully (Chainstack).

If you’re aiming at regulated use cases, don’t rely on “freeze-and-seize exists” as your whole compliance story. You’ll still need documented procedures, event logs, and disclosures so users understand the circumstances under which you’ll exercise those controls.

What are the risks and trade-offs for holders and developers?

Centralized levers. Freeze-and-seize, blocklists, and role hierarchies can be useful, but they introduce issuer discretion. That’s a problem for censorship-resistance purists and a feature for compliance-minded teams. Either way, investors deserve clear disclosure.

Migration friction. If you’re porting an ERC-20 to B20, there’s no magic “convert” switch. You’ll likely mint a B20 version, set up migration or swap flows, and communicate carefully. Expect double-ticker confusion unless you make the path obvious.

Tooling lag. Selector parity means wallets and indexers should basically work. But specialized features — like reading policy states or listing issuer roles — may need explorer updates. Some analytics and bridges could take a beat to support the B20 factory metadata.

Execution assumptions. Precompiles can reduce custom contract risk and, in some cases, improve efficiency. Still, you’re trusting the chain’s implementation and upgrade process. Read the Base changelog and follow upgrade notes so you’re not surprised by behavioral tweaks (Base — Upgrades changelog).

Infographic of DEXTools’ July 9, 2026 first‑day B20 census — shows ~2,000 tokens created in a ~7‑hour window, 98.4% asset (18‑decimal) variant and 64% with a 1,000,000,000 supply, illustrating the day‑one memecoin surge. — Source: DEXTools News

Will fees in B20 tokens actually arrive, and what would that change?

Base’s roadmap calls out planned B20 enhancements tied to the Cobalt phase, including the ability to pay transaction fees in B20 assets as part of an EIP‑8130 rollout path. It’s listed as a planning entry, not a live feature, but it’s on the official board (Base — Upgrades changelog).

If enabled, fee payment in B20 could soften the classic cold-start problem for new tokens. New users wouldn’t need ETH for gas to move or stake a token; they could pay in the asset itself. That’s great for UX and community growth, but it adds economic design questions around gas pricing, slippage on fee conversions, and abuse vectors. Treat it as a meaningful “watch this space,” not a done deal.

Common Mistakes

1. Not verifying the factory path. If a token doesn’t originate from 0xB20f… and the address doesn’t start 0xB200…, you might be looking at a contract clone. Check event logs and the factory registry before integrating.
2. Assuming immutability. B20’s roles and policies mean controls exist by design. If you require permissionless behavior, read the policy state before buying or providing liquidity.
3. Over-tight transfer rules. Aggressive blocklists or narrow allowlists can trap user funds or kill pool depth. Pilot with small cohorts and monitor revert reasons on transfers.
4. Ignoring permit. Skipping ERC‑2612 means more failed approvals and higher friction. Enable it and make sure your frontends request signatures correctly.
5. Supply optics games. Launching with 1,000,000,000 supply because “that’s what memes do” tells on you. Pick decimals and supply that fit your economics, not a template.
6. Assuming bridges support B20 on day one. Many bridges prioritize standard ERC-20s. Confirm B20 integration before trying to move assets cross-chain.

If you want ongoing coverage of Base upgrades, token standards, and the knocks they take in the wild, we track it closely at Crypto Daily.

Frequently Asked Questions

Can I convert an existing ERC-20 into a B20 without breaking markets?

There’s no in-place conversion. The usual path is to mint a B20 version, set up a swap or migration contract, and communicate a clear cutoff plan. Some teams dual-list during a transition window, but that adds confusion, so keep the overlap short and explicit.

Do B20 tokens work everywhere ERC-20s do?

For basic transfers and approvals, yes — B20 mirrors ERC-20 selectors, so wallets and most dApps treat them as fungible tokens. The issuer-only features are new, so explorers and analytics may need updates to surface policy state or role assignments. Expect that to improve over time.

How do I verify a token is a real B20 and not a lookalike?

Check the provenance. Confirm the mint came from the factory at 0xB20f000000000000000000000000000000000000 and that the token address begins with 0xB200…. Cross-check registry events and avoid tokens that can’t prove a factory origin (Chainstack).

Are transfer memos public, and should I worry about privacy?

Memos are optional metadata. If an issuer enables them, they become part of the token’s on-chain data surface, which is public by default. Don’t include sensitive information; use them for operational breadcrumbs like issuance notes or compliance references.

What happens if an issuer’s admin keys are compromised?

Role-based controls cut both ways. Good setups separate duties and include emergency procedures: freeze suspicious flows, rotate keys, and publish an incident notice. If you hold a token, check whether the issuer has documented recovery steps before you size up exposure.

Can B20 exist outside Base?

B20 is native to Base as a precompile. Other chains would need to implement their own equivalent. You can bridge value or wrap representations to other networks, but those wrappers won’t have Base’s native issuer controls unless the destination chain supports them.

Did launch data imply B20 is only for memes?

No — it implied that mint friction invites experimentation. Early logs showed thousands of quick mints with meme-style parameters and no serious RWAs or stablecoins in a small sample (DEXTools News). Expect more sober use cases as tooling and policy patterns settle.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

* This article was originally published here

Licensed Web3 Sportsbooks for Football, NHL and MLB

Crypto betting has moved well beyond niche Bitcoin casinos. Today's Web3 sportsbooks combine licensed gambling operations with blockchain payments, wallet connectivity, and faster settlements. Many also support dozens of cryptocurrencies, allowing bettors to move between Bitcoin, Ethereum, USDT, Solana, TRON, and other assets without relying on traditional banking.

The challenge is that not every crypto sportsbook delivers the same experience. Some focus primarily on casino games and treat sports as a secondary product. Others offer excellent football coverage but only basic markets for North American leagues. Licensing is another important distinction. A licensed operator must comply with regulatory standards, while blockchain features add transparency and payment flexibility.

This review looks at five licensed Web3 sportsbooks that perform particularly well for three of the world's most popular betting markets:

• Football (soccer)

• NHL

• MLB

What Makes a Good Web3 Sportsbook?

A modern crypto sportsbook should provide more than cryptocurrency deposits. The strongest platforms combine several features.

• A recognized gambling license

• Multi-chain crypto support

• Competitive odds

• Extensive live betting

• Fast crypto withdrawals

• Wallet connectivity

• Transparent settlement procedures

• Responsive mobile experience

Football bettors usually look for broad league coverage and live markets. NHL bettors benefit from sportsbooks with frequent odds updates during games, while MLB bettors need reliable live betting throughout every inning.

Licensed Web3 Sportsbooks

Sportsbook

License

Crypto Support

Best For

Dexsport

Anjouan

40+ cryptocurrencies

Overall Web3 experience

Cloudbet

Offshore licensed

30+ cryptocurrencies

High-volume sports betting

Stake

Offshore licensed

17+ cryptocurrencies

Large crypto ecosystem

Vave

Curaçao

Multiple cryptocurrencies

Football markets

Thunderpick

Offshore licensed

Crypto only

Esports and traditional sports

1. Dexsport

Dexsport is one of the few sportsbooks built around blockchain rather than simply accepting cryptocurrency payments. Players can connect MetaMask, Trust Wallet, or register with email or Telegram, while keeping control over how they fund their accounts.

The platform supports more than 40 cryptocurrencies across 20 blockchain networks, making it one of the broadest selections among licensed sportsbooks. Football receives particularly strong coverage, ranging from domestic leagues to Champions League and international tournaments. NHL and MLB are equally well represented with pre-match and live betting.

One feature that separates Dexsport from many competitors is its public betting desk. Bets and settlements can be viewed transparently, giving players additional confidence in how wagers are handled. The platform has also undergone audits by CertiK and Pessimistic and operates under an Anjouan gaming license.

Highlights

• 40+ cryptocurrencies across 20 networks

• MetaMask and Trust Wallet support

• No mandatory KYC for standard play

• Cash Out on live bets

• Transparent on-chain betting records

• Strong football, NHL, and MLB coverage

2. Cloudbet

Cloudbet has been serving crypto bettors since 2013, making it one of the longest-running sportsbooks in the industry. Rather than chasing casino promotions, it has focused on building a sportsbook with deep markets and high betting limits.

Football coverage extends across Europe's top leagues, international competitions, and lower divisions. NHL and MLB are equally comprehensive, making Cloudbet particularly attractive for North American sports fans.

The sportsbook supports more than 30 cryptocurrencies and generally processes withdrawals automatically within minutes or hours, depending on network congestion.

Highlights

• Excellent football, NHL, and MLB coverage

• High betting limits

• 30+ cryptocurrencies

• Competitive odds

• Fast automated withdrawals

3. Stake

Stake has become one of the largest names in crypto gambling, combining sportsbook and casino products under a single account.

The sportsbook covers more than 30 sports with extensive live betting, streaming, and Cash Out functionality. Football receives the deepest coverage, while NHL and MLB offer competitive odds and numerous betting options throughout the season.

Stake accepts more than 17 cryptocurrencies and provides one of the strongest live betting interfaces currently available. Players should note that identity verification is required before withdrawals.

Highlights

• Excellent football markets

• Live streaming

• Cash Out

• Competitive sportsbook margins

• Large cryptocurrency selection

4. Vave

Vave combines sportsbook and casino gaming within a modern interface that performs particularly well on mobile devices.

Football is clearly the platform's strongest category. Major European matches often include hundreds of available betting markets, while NHL and MLB coverage remains solid throughout the season.

The sportsbook supports numerous cryptocurrencies and provides live betting, streaming, and player proposition markets. Identity verification generally takes place during larger withdrawals rather than registration.

Highlights

• Deep football markets

• Live betting

• Cash Out

• Mobile-friendly interface

• Good cryptocurrency support

5. Thunderpick

Thunderpick originally built its reputation through esports, but its traditional sportsbook has expanded considerably over the past few years.

Football remains the strongest conventional sport, while NHL and MLB coverage continues to improve. Bettors interested in combining traditional sports with CS2, Dota 2, Valorant, or League of Legends will appreciate having everything available under one account.

The sportsbook is entirely crypto-based and supports several major digital assets for deposits and withdrawals.

Highlights

• Strong esports offering

• Football, NHL, and MLB coverage

• Crypto-only platform

• Regular sportsbook promotions

Which Sportsbook Performs Best by Sport?

Football

Football demands broad league coverage, fast live odds, and numerous betting markets.

Top choices

1. Dexsport

2. Cloudbet

3. Stake

4. Vave

5. Thunderpick

NHL

Hockey bettors benefit from sportsbooks that update live odds quickly and offer a wide range of player and game markets.

Top choices

1. Cloudbet

2. Dexsport

3. Stake

4. Vave

5. Thunderpick

MLB

Baseball rewards sportsbooks that provide stable live betting throughout every inning and support advanced betting markets.

Top choices

1. Cloudbet

2. Dexsport

3. Stake

4. Vave

5. Thunderpick

Choosing the Right Platform

The best sportsbook depends on what matters most.

Cloudbet remains one of the strongest choices for experienced sports bettors who prioritize market depth and high betting limits. Stake delivers one of the largest crypto gambling ecosystems with an excellent live betting interface. Thunderpick is particularly attractive for players who divide their time between esports and traditional sports.

Dexsport offers the most complete Web3 experience. It combines a gambling license, extensive multi-chain support, wallet connectivity, blockchain transparency, and comprehensive coverage of football, NHL, and MLB. For bettors looking for a sportsbook built around cryptocurrency rather than simply accepting it as a payment method, it stands out as one of the strongest options available today.

 

 

 

Disclaimer: The information here is provided for general purposes only and is not legal, tax, investment, or financial advice, and nothing here is a betting tip or prediction. Market availability and platform features change over time, so confirm current details before betting. Betting carries risk, and rules vary by country, so check the law where you live. Please gamble responsibly, within your means, and only if you are of legal age.

* This article was originally published here

AbbVie Earnings: Can Skyrizi and Rinvoq Replace Humira?

Picture an earnings call where one question keeps looping: can two fast-growing immunology drugs really replace a mega-blockbuster that defined a decade of pharma profits? That’s the AbbVie story in a sentence.

Portfolio managers now model every quarter around the same pivot: Humira is sliding post-biosimilars; Skyrizi and Rinvoq are sprinting. The gap is the whole ballgame.

If you care about cash flow durability, margins, and what happens when a moat meets generics, this is the stack to watch.

Humira’s patent exclusivity broke in Europe years ago and in the U.S. in 2023, opening the door to a swarm of adalimumab biosimilars. That forced AbbVie to do what every big pharma hopes it never has to do: rebuild the core from inside. The plan is clear enough. Let Humira decline at a managed pace while Skyrizi (risankizumab, an IL‑23 inhibitor) and Rinvoq (upadacitinib, a selective JAK inhibitor) scale across dermatology, rheumatology, and gastroenterology.

AbbVie’s earnings hinge on a handoff: defend Humira’s base just long enough for Skyrizi and Rinvoq to reach escape velocity across multiple indications and geographies.

Why now? Because post‑loss‑of‑exclusivity curves don’t wait. Payers re-tier. Net prices reset. Prescribers experiment. Patients ask about cheaper options. The company either backfills revenue fast or the P&L re-rates.

Humira’s Peak, Then the Patent Cliff

Humira was the archetypal mega‑blockbuster: multiple autoimmune indications, years of IP layers, and a massive commercial engine. But time always wins. Europe saw biosimilars earlier, and the U.S. followed in 2023 as a pack of adalimumab copies arrived, including interchangeable versions like Cyltezo, validated at the agency level by the FDA years prior (FDA).

The erosion mechanics are familiar. You get a stair‑step decline as contracts renew, formularies shift, and net price blends compress. The question for investors isn’t whether Humira declines. It’s the slope of the line and whether new revenue can outrun it.

How Skyrizi and Rinvoq Are Built to Take Share

Skyrizi and Rinvoq weren’t accidents. AbbVie designed them to cover broad autoimmune ground, with mechanisms that fit the current standard of care debates: targeted cytokine inhibition for Skyrizi; a potent but selective JAK for Rinvoq. Each one has stacked indications over time as data matured and regulators weighed in.

Indications and label expansion

Skyrizi first broke through in moderate to severe plaque psoriasis, then gathered momentum in psoriatic arthritis and inflammatory bowel disease as data landed. U.S. labels reflect that breadth today, spanning psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis (AbbVie Prescribing Information).

Rinvoq started in rheumatoid arthritis and has since expanded into atopic dermatitis, psoriatic arthritis, ankylosing spondylitis/axial spondyloarthritis, ulcerative colitis, and Crohn’s disease, among others, following rigorous clinical programs and risk‑benefit reviews (AbbVie Prescribing Information).

Those expansions matter. Each new indication extends the total addressable market, allows multi‑specialty detailing, and opens new payer contracts. It’s the difference between a niche therapy and a platform franchise.

Access, payer math, and prescriber habits

Market access is the unglamorous engine here. With Humira facing cheaper biosimilars, payers pressure the class on price. But payers and prescribers also value clinical differentiation: dosing convenience, durable response, and safety profiles adapted to long‑term use. That’s where Skyrizi’s IL‑23 story and Rinvoq’s efficacy in difficult‑to‑treat populations give AbbVie real talking points.

It’s rarely linear, though. Prior authorization, step therapy, and rebates can make uptake lumpy quarter to quarter. And for Rinvoq, JAK class scrutiny means more paperwork and careful patient selection, even with selective targeting and extensive safety data baked into labels and REMS where relevant.

1. Humira biosimilars launch, payers re-tier formularies and renegotiate.
2. Net prices for adalimumab class compress; prescribers test biosimilars in stable patients.
3. New starts and switchers seek best efficacy/convenience; Skyrizi and Rinvoq compete on data and dosing.
4. Payer contracts evolve with indication breadth; access improves as outcomes evidence accrues.
5. Franchise scale lowers unit costs; commercial reach compounds across specialties.

What Recent Earnings Have Actually Shown

Across recent quarters, the pattern has been pretty consistent: Humira down as expected post‑U.S. biosimilars, while Skyrizi and Rinvoq post strong year‑over‑year growth and sequential gains. Management has repeatedly framed the pair as the company’s primary growth engine and has suggested, in public remarks and investor materials, that they’re positioned to ultimately surpass Humira’s contribution over time, assuming continued execution and label breadth (AbbVie IR).

It’s worth remembering this isn’t just a sales contest. Skyrizi and Rinvoq sell into categories where outcome measures are getting sharper. Dermatology values clear skin rates and durability. GI cares about histologic remission and steroid‑free maintenance. Rheumatology tracks function and flares. AbbVie’s trials have been built around those endpoints, which is central to prescribing behavior and payer decisions.

Franchise Mechanism Key Indications (US) Administration Competitive Set Commercial Notes Humira (adalimumab) TNF inhibitor Multiple autoimmune (legacy) Subcutaneous TNF class + many biosimilars Net price compression after 2023 U.S. biosimilar entry; high brand recognition Skyrizi (risankizumab) IL‑23 inhibitor Psoriasis, PsA, Crohn’s, UC Subcutaneous; IV induction in GI IL‑23/IL‑17/IL‑12/23 rivals Strong skin clearance profile; convenient maintenance dosing; expanding GI footprint Rinvoq (upadacitinib) Selective JAK RA, AD, PsA, AS/axSpA, UC, Crohn’s Oral, once daily JAKs and targeted biologics High efficacy in difficult disease; class safety monitoring and labeling influence access

Regulatory context supports the breadth. U.S. approvals for Skyrizi in psoriasis came first, then psoriatic arthritis and GI indications as data matured; Rinvoq’s initial RA approval extended into dermatology and IBD following robust phase 3 programs and further safety label updates along the way (FDA Approvals Database).

Pricing, Competition, and the Margin Story

Let’s talk math. Humira’s contribution was never just volume. It was margin heft from a mature brand with optimized manufacturing and a long tail of loyal prescribers. Replacing that is about volume and mix. Net prices in immunology are pressured by biosimilars on one side and rival brands on the other. AbbVie can’t ignore either.

Class competition is real

Skyrizi competes in a crowded biologics space where IL‑23s and IL‑17s have real followings. The pitch is efficacy, dosing convenience, and durability. In GI, it also faces anti‑integrins and other targeted mechanisms. That’s healthy competition, but it means share gains are earned, not gifted.

Rinvoq competes against other JAKs and against biologics favored by certain payers for safety familiarity. The JAK class has had higher regulatory scrutiny, including boxed warnings and post‑marketing requirements, which shape prescriber comfort and payer criteria. That doesn’t preclude growth; it just requires relentless data generation and precise positioning.

Net pricing and access pressure

Biosimilars pull reference pricing down across categories, even if not directly substitutable. Expect continuing negotiation cycles as large PBMs and plans attempt to capture savings. For AbbVie, the lever is differentiation proven in head‑to‑head or meaningful indirect comps, plus label expansions that unlock broader contracts.

Manufacturing and patient experience

Friction matters. Skyrizi’s maintenance schedule is a selling point for adherence. Rinvoq’s oral dosing is patient‑friendly. But reliability, supply continuity, and support programs can be tie‑breakers. AbbVie has scale, which helps. It still needs to keep fulfillment boringly predictable.

What To Watch Over the Next Few Earnings Cycles

If you want to know whether Skyrizi and Rinvoq can fully replace Humira, track a handful of concrete milestones and signals.

1. U.S. and ex‑U.S. indication breadth: Any new approvals or earlier‑line placements for either drug can expand eligible populations. Keep an eye on label updates posted through official channels like the FDA and AbbVie’s own disclosures (AbbVie IR).
2. Access wins: Watch remarks on formulary positioning, step‑edits removed, and time‑to‑treatment metrics. These often show up in Q&A on earnings calls or slide decks.
3. Real‑world outcomes: New data on durability, steroid‑free remission, or skin clearance at high thresholds (like PASI 90/100) can reinforce differentiation and support earlier use.
4. International mix: As Europe and other markets normalize post‑LOE dynamics in their own ways, ex‑U.S. growth for Skyrizi/Rinvoq becomes more important to fill the global hole.
5. Manufacturing and supply: Any scale‑up milestones or site validations that de‑risk supply constraints for subcutaneous and oral inventories will matter to sustained growth.
6. Safety communications: Updated class guidance for JAKs or new long‑term safety readouts can influence prescriber comfort and payer criteria for Rinvoq in particular.

Risks & What Could Go Wrong

• Uptake lags: If payer hurdles or prescriber caution slow new starts, growth could underwhelm while Humira erosion continues.
• Pricing compression: Competitive rebating or biosimilar adjacency could squeeze net prices faster than volume ramps.
• Safety headlines: Class‑wide JAK concerns or unexpected safety signals could lead to label changes or tighter access for Rinvoq.
• Clinical misses: Any negative late‑stage readout or a competitor’s superior data in a core indication could dent share curves.
• Supply chain hiccups: Capacity constraints or quality holds would quickly show up as missed demand in high‑growth markets.
• Macroeconomic pressure: Higher patient cost‑sharing or plan design changes could delay starts or increase discontinuations.

Replacement isn’t a single quarter event; it’s a sequence of flawless quarters. A wobble in access, safety, or pricing can push the crossover further out.

Where I’m Tracking This Story

If you want a steady drumbeat on how immunology franchises are trending around earnings season, I keep an eye on company filings and primary sources. For broader market color and how biotech intersects with risk appetite across assets, I also read outlets like Crypto Daily to see how flows and sentiment are shifting at the macro level. Different market, same discipline: watch the data, ignore the noise.

Frequently Asked Questions

What exactly are Skyrizi and Rinvoq replacing?

They’re positioned to backfill revenue and profit that AbbVie historically drew from Humira, a top‑selling anti‑TNF biologic that’s now under intense biosimilar pressure in the U.S. and already faced it in Europe. The replacement goal is financial, not therapeutic one‑for‑one.

How do Skyrizi and Rinvoq work differently from Humira?

Humira targets TNF, a broad inflammatory cytokine. Skyrizi selectively inhibits IL‑23, which has shown strong skin and GI outcomes. Rinvoq is a selective JAK inhibitor, oral and potent, affecting intracellular signaling pathways. Different mechanisms, overlapping disease areas.

Is there a clear timeline for when the pair might surpass Humira?

Management has suggested the combination is positioned to overtake Humira’s contribution over time as labels expand and access improves, but exact timing depends on uptake, pricing, and competition. Watch consecutive quarters of double‑digit growth and commentary from AbbVie IR for clues.

What are the biggest bottlenecks to faster adoption?

Payer controls like step therapy and prior authorization, prescriber caution around JAK class safety for Rinvoq, and competition from other biologics in dermatology, rheumatology, and GI. Supply reliability and patient support programs also influence real‑world uptake.

Do biosimilars to Humira directly hurt Skyrizi and Rinvoq?

Indirectly. Cheaper adalimumab options push down immunology net price expectations. That can make payers tougher negotiators across the board. Still, if clinical differentiation is clear, premium brands can keep favorable access and share.

Which datapoints should investors watch each quarter?

Year‑over‑year and sequential sales growth for Skyrizi and Rinvoq, Humira decline slope, commentary on formulary wins, any label updates, and margin trends. Also note any safety communications or manufacturing updates in press releases or filings.

Where can I verify approvals and labels?

Check the FDA’s approvals and labeling database for official updates (FDA) and the current U.S. Prescribing Information for Skyrizi and Rinvoq provided by AbbVie (Skyrizi PI; Rinvoq PI).

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

* This article was originally published here

How Crypto Casino Licensing Differs Across Europe

"Licensed in Europe" sounds like a single standard, and it is not. Europe contains some of the strictest gambling regulators in the world and some of the lightest, and the distance between them decides how much protection a player actually has.

A licence from one European jurisdiction can mean segregated funds and a binding disputes body; from another, far less.

This walks through the main European licensing regimes a crypto casino might hold, what each brings a player, and why most crypto-first casinos sit outside the strictest of them. The continent is not one market but many, and the licence tells you which one you are in.

Europe Is Not a Single Regulator

The first thing to unlearn is that a European licence is a uniform guarantee. Gambling regulation in Europe is national, not continental, so each country sets its own regime, and they vary enormously.

Shared standards come through the European Union's anti-money-laundering directives, but licensing itself stays with member states and a few well-known non-EU jurisdictions.

So a casino "licensed in Europe" could be under a rigorous EU regulator or a lighter one, and the country named is what matters, not the continent.

Malta: The EU Tier-1 Standard

The Malta Gaming Authority is the reference point for serious online gambling regulation in the EU, and the strictest a crypto casino commonly holds.

An MGA licence brings segregated player funds held separately from operating capital, a binding player-protection disputes process, and access to the EU market under a recognised regulator.

It is demanding and expensive to obtain, which is precisely why relatively few crypto-first casinos carry it, and why the ones that do can point to it as a genuine mark of standing. For a player, a Malta licence is the strongest routine assurance available in Europe.

Estonia, Isle of Man and Gibraltar: Established Regimes

Below Malta sit several well-regarded European regimes, each with its own character.

Estonia licenses online gambling under an EU framework, with a modern regulator that has become a credible base for operators wanting EU standing without Malta's scale. The Isle of Man and Gibraltar, both outside the EU but long-established in gambling, run respected regimes with strong reputations, particularly among larger operators. Each brings meaningful oversight and player protection, and while their specifics differ, all three sit well above the lightest offshore options, and what a given regime actually covers is worth checking against the country named.

Curacao: European-Facing but Not European

Curacao deserves a place here because it licenses so many crypto casinos serving European players, even though it is not a European regulator.

In recent years Curacao overhauled its framework, moving to direct licensing by its Gaming Authority with a public register and stronger oversight than its old sublicence system offered.

It is more credible than it was, but it remains a Caribbean jurisdiction, not an EU one, so a Curacao-licensed casino serving European players does not carry EU-level protections like segregated funds or a binding EU disputes body.

Dexsport's Licensing and European Players

Dexsport holds an Anjouan licence, which is an offshore regime outside Europe entirely, and lighter than Malta, Estonia or the Isle of Man. Stating that plainly is the honest starting point for any European player weighing the platform.

What that means in practice is thinner formal recourse than an EU licence provides: there is no EU segregated-funds requirement or binding European disputes body behind an Anjouan licence.

Where Dexsport answers part of that structurally is its non-custodial model, which keeps a settled balance in a wallet the player holds instead of an operator account, and its public on-chain desk, which records settlement independently.

Those are real features, and they are a different kind of assurance from an EU licence, not a substitute for one. A European player should weigh the lighter licence against the self-custody model directly. Anjouan also excludes several territories, so players should confirm their own jurisdiction is served.

Reading a European Licence for What It Is

The practical takeaway is to read the specific jurisdiction, never the word "Europe." A Malta or Estonia licence carries EU-level protections; an Isle of Man or Gibraltar licence carries a strong established regime; a Curacao or Anjouan licence is offshore, lighter, and outside EU protections however it is marketed.

Verifying the licence on the regulator's own register is the step that confirms which of these you are actually dealing with.

Confirm what is legal where you live, keep stakes within a set budget, and play only if you are of legal age, since KYC or AML checks may apply. Responsible gambling matters under every regime, because the strongest European licence does not change the house edge on a single game.

 

 

 

Disclaimer: The information here is provided for general purposes only and is not legal, tax, investment, or financial advice. Licensing regimes and their requirements vary by jurisdiction and change over time, so confirm current details with the relevant authority. Betting carries risk, and rules vary by country, so check the law where you live. Please gamble responsibly, within your means, and only if you are of legal age.

* This article was originally published here

Ultimate Guide To Trading Crypto News in 2026

* This article was originally published here